Advisory Services Network’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-113
Closed -$21K 3653
2021
Q2
$21K Sell
113
-8,349
-99% -$1.43M ﹤0.01% 2488
2021
Q1
$1.29M Sell
8,462
-319
-4% -$49.3K 0.05% 468
2020
Q4
$1.37M Sell
8,781
-92
-1% -$11.8K 0.06% 407
2020
Q3
$1.02M Sell
8,873
-2
-0% -$216 0.05% 411
2020
Q2
$997K Sell
8,875
-56
-0.6% -$5.95K 0.05% 388
2020
Q1
$802K Buy
8,931
+811
+10% +$79.6K 0.05% 396
2019
Q4
$878K Buy
8,120
+7,323
+919% +$783K 0.05% 461
2019
Q3
$105K Hold
797
0.01% 1049
2019
Q2
$105K Buy
797
+585
+276% +$75.4K 0.01% 1047
2019
Q1
$29K Sell
212
-744
-78% -$92.5K ﹤0.01% 1462
2018
Q4
$93K Buy
956
+76
+9% +$8.98K 0.01% 924
2018
Q3
$123K Sell
880
-3
-0.3% -$376 0.01% 902
2018
Q2
$121K Buy
883
+523
+145% +$61.1K 0.01% 876
2018
Q1
$40K Buy
360
+29
+9% +$3.47K ﹤0.01% 1408
2017
Q4
$40K Buy
331
+312
+1,642% +$38K ﹤0.01% 1382
2017
Q3
$3K Buy
19
+11
+138% +$1.49K ﹤0.01% 2104
2017
Q2
$1K Sell
8
-570
-99% -$66.3K ﹤0.01% 2259
2017
Q1
$70K Buy
+578
New +$74.5K 0.01% 897
2016
Q3
$6K Sell
53
-33
-38% -$4.25K ﹤0.01% 1483
2016
Q2
$10K Buy
86
+78
+975% +$11.1K ﹤0.01% 1218
2016
Q1
$1K Sell
8
-625
-99% -$91.8K ﹤0.01% 1635
2015
Q4
$121K Buy
633
+625
+7,813% +$109K 0.04% 406
2015
Q3
$1K Sell
8
-233
-97% -$42.5K ﹤0.01% 1471
2015
Q2
$44K Buy
241
+229
+1,908% +$39.5K 0.01% 545
2015
Q1
$2K Hold
12
﹤0.01% 1211
2014
Q4
$2K Buy
+12
New +$2.22K ﹤0.01% 1123

Other funds holding ALXN